These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 25633010)

  • 21. Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital.
    Lee AS; Macedo-Vinas M; François P; Renzi G; Vernaz N; Schrenzel J; Pittet D; Harbarth S
    J Hosp Infect; 2011 Apr; 77(4):360-2. PubMed ID: 21276638
    [No Abstract]   [Full Text] [Related]  

  • 22. Chlorhexidine and Mupirocin Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates in the REDUCE-MRSA Trial.
    Hayden MK; Lolans K; Haffenreffer K; Avery TR; Kleinman K; Li H; Kaganov RE; Lankiewicz J; Moody J; Septimus E; Weinstein RA; Hickok J; Jernigan J; Perlin JB; Platt R; Huang SS
    J Clin Microbiol; 2016 Nov; 54(11):2735-2742. PubMed ID: 27558180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus.
    Mercer DK; Katvars LK; Hewitt F; Smith DW; Robertson J; O'Neil DA
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28607014
    [No Abstract]   [Full Text] [Related]  

  • 24. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis.
    Hurdle JG; O'Neill AJ; Mody L; Chopra I; Bradley SF
    J Antimicrob Chemother; 2005 Dec; 56(6):1166-8. PubMed ID: 16275681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The detection of mupirocin resistance and the distribution of methicillin-resistant Staphylococcus aureus at the University Hospital of the West Indies, Jamaica.
    Nicholson AM; Thorns C; Wint H; Didier M; Willis R; McMorris N; Castle D; Maharaj N; Orrett FA
    West Indian Med J; 2010 Oct; 59(5):509-13. PubMed ID: 21473397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eradication of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit: which measures for which success?
    Lepelletier D; Corvec S; Caillon J; Reynaud A; Rozé JC; Gras-Leguen C
    Am J Infect Control; 2009 Apr; 37(3):195-200. PubMed ID: 19181423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
    Wertheim HF; Vos MC
    Crit Care; 2005 Jun; 9(3):257-8. PubMed ID: 15987417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA.
    Poovelikunnel T; Gethin G; Humphreys H
    J Antimicrob Chemother; 2015 Oct; 70(10):2681-92. PubMed ID: 26142407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotic ointments and methicillin-resistant Staphylococcus aureus with a reservoir in a healthcare worker in a tertiary hospital].
    Molina-Cabrillana J; Del Rosario-Quintana C; Tosco-Núñez T; Dorta-Hung E; Quori A; Martín-Sánchez AM
    Enferm Infecc Microbiol Clin; 2013 Oct; 31(8):511-5. PubMed ID: 23218870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA.
    Sandri AM; Dalarosa MG; Ruschel de Alcantara L; da Silva Elias L; Zavascki AP
    Infect Control Hosp Epidemiol; 2006 Feb; 27(2):185-7. PubMed ID: 16465636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Activity of mupirocin against methicillin-resistant Staphylococcus aureus isolated in Pontevedra province].
    Potel C; Alvarez P; Constenla L; Alvarez M
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):59-60. PubMed ID: 19218007
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of mupirocin resistance on the transmission and control of healthcare-associated MRSA.
    Deeny SR; Worby CJ; Tosas Auguet O; Cooper BS; Edgeworth J; Cookson B; Robotham JV
    J Antimicrob Chemother; 2015 Dec; 70(12):3366-78. PubMed ID: 26338047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An outbreak of infection with a methicillin-resistant Staphylococcus aureus in a special care baby unit: value of topical mupirocin and of traditional methods of infection control.
    Davies EA; Emmerson AM; Hogg GM; Patterson MF; Shields MD
    J Hosp Infect; 1987 Sep; 10(2):120-8. PubMed ID: 2889764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of prevalence of low and high level mupirocin resistance in methicillin resistant Staphylococcus aureus isolates at a tertiary care hospital.
    Nizamuddin S; Irfan S; Zafar A
    J Pak Med Assoc; 2011 Jun; 61(6):519-21. PubMed ID: 22204200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units.
    Muller A; Talon D; Potier A; Belle E; Cappelier G; Bertrand X
    Crit Care; 2005 Jun; 9(3):R246-50. PubMed ID: 15987397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride.
    Rohr U; Mueller C; Wilhelm M; Muhr G; Gatermann S
    J Hosp Infect; 2003 Aug; 54(4):305-9. PubMed ID: 12919762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decrease in the incidence of mupirocin resistance among methicillin-resistant Staphylococcus aureus in carriers from an intensive care unit.
    Caierão J; Berquó L; Dias C; d'Azevedo PA
    Am J Infect Control; 2006 Feb; 34(1):6-9. PubMed ID: 16443086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coexistence of mupirocin and antiseptic resistance in methicillin-resistant Staphylococcus aureus isolates from Korea.
    Lee H; Lim H; Bae IK; Yong D; Jeong SH; Lee K; Chong Y
    Diagn Microbiol Infect Dis; 2013 Mar; 75(3):308-12. PubMed ID: 23337107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mupirocin for controlling methicillin-resistant Staphylococcus aureus: lessons from a decade of use at a university hospital.
    Vivoni AM; Santos KR; de-Oliveira MP; Giambiagi-deMarval M; Ferreira AL; Riley LW; Moreira BM
    Infect Control Hosp Epidemiol; 2005 Jul; 26(7):662-7. PubMed ID: 16092750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk.
    Robicsek A; Beaumont JL; Thomson RB; Govindarajan G; Peterson LR
    Infect Control Hosp Epidemiol; 2009 Jul; 30(7):623-32. PubMed ID: 19496730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.